Skip to main content
. 2016 Sep 5;129(17):2102–2108. doi: 10.4103/0366-6999.189047

Figure 2.

Figure 2

Effects of ubiquitin-specific protease 8 inhibitor on cell viability of liver, renal, and adrenal cells. Cells were incubated for 24 h with 1–10 μmol/L ubiquitin-specific protease 8 inhibitor; control cells were treated with vehicle solution. HEK 293T (a), Hepa 1-6 (b), PC12 (c), cell viability was assessed in at least three independent experiments with six replicates.